Life
Significant Decline in Antibiotic Development by Major Drugmakers
A recent analysis indicates that the world’s largest pharmaceutical companies have reduced their antibiotic development efforts by 35% over the last five years, raising concerns about future antimicrobial capacity.
Editorial Staff
1 min read
The analysis reveals a notable decrease in the number of potential antimicrobial treatments being developed by leading drug manufacturers.
Specifically, the report highlights a 35% decline in antibiotic development efforts over the past five years.
This trend poses significant implications for public health infrastructure and the ability to combat antibiotic-resistant infections in the future.